Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Cash flows from operating activities:
Net (loss)	$ (521,414)	$ (1,059,824)
Adjustments to reconcile net loss to net cash (used in) operating activities
Depreciation		759
Common stock issued for services rendered	234,036	683,430
Accounts payable and accrued expenses	(34,578)	(4,972)
Due from related party	(12,054)	(23,339)
Net cash (used in) operating activities:	(334,010)	(403,946)
Cash flows from investing activities
Patent cost	(7,000)
Net cash (used in) investing activities:	(7,000)
Cash flows from financing activities
Proceeds from issuance of common stock	250,000
Proceeds from exercise of options		58,000
Proceeds from exercise of warrants		118,446
Repayment of officer loan payable		(2,400)
Net cash provided by financing activities	250,000	174,046
Net increase/(decrease) in cash	250,000	(229,900)
Cash and cash equivalents beginning of period	152,526	400,848
Common stock issued for payable	234,036	72,375
Deferred revenue		276,950
Interest
Income taxes